Reports for HYDROCHLOROTHIAZIDE
Ingredient
HYDROCHLOROTHIAZIDE
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CANDESARTAN-HCTZ | 12.5MG 16.0MG | TABLET | Resolved | 2024-05-03 | 2024-05-16 | 227037 |
| PMS-CANDESARTAN-HCTZ | 12.5MG 16.0MG | TABLET | Resolved | 2017-03-24 | 2017-04-07 | 4171 |
| PMS-CANDESARTAN-HCTZ | 12.5MG 16.0MG | TABLET | Resolved | 2017-07-25 | 2018-01-26 | 17024 |
| PMS-CANDESARTAN-HCTZ | 12.5MG 16.0MG | TABLET | Resolved | 2018-04-20 | 2019-02-26 | 46692 |
| TEVA-OLMESARTAN / HCTZ | 25MG 40MG | TABLET | Resolved | 2018-10-22 | 2020-06-11 | 65346 |
| SANDOZ LOSARTAN HCT | 12.5MG 50MG | TABLET | Resolved | 2019-01-22 | 2020-08-17 | 73158 |
| SANDOZ LOSARTAN HCT | 12.5MG 50MG | TABLET | Resolved | 2019-01-22 | 2020-09-15 | 73161 |
| SANDOZ LOSARTAN HCT | 12.5MG 50MG | TABLET | Resolved | 2021-09-08 | 2022-12-12 | 145343 |
| SANDOZ LOSARTAN HCT | 12.5MG 50MG | TABLET | Resolved | 2021-09-08 | 2023-05-03 | 145346 |
| SANDOZ LOSARTAN HCT | 12.5MG 50MG | TABLET | Resolved | 2023-05-01 | 2023-05-09 | 191382 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65050 | ||
| ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65052 | ||
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65068 | ||
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65071 | ||
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65074 | ||
| RAMIPRIL-HCTZ | Discontinued | 2018-12-21 | 2018-12-22 | 70392 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 |